Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IL-6 | 100 | ug/mL | 3 | IL-15 | 112.0 | 65 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | IL-15 | 104.5 | 66 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-15 | 107.5 | 54 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-15 | 114.0 | 59 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-15 | 105.0 | 75 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | IL-15 | 114.0 | 64 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | IL-15 | 97.0 | 66 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 3 | IL-15 | 141.0 | 65 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-15 | 139.5 | 58 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-15 | 131.0 | 69 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-15 | 155.0 | 69 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-15 | 163.5 | 66 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-15 | 111.0 | 71 | |
RA2159 | PI103 | 0.1 | uM | 3 | IL-15 | 112.0 | 62 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 3 | IL-15 | 153.0 | 69 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-15 | 143.5 | 64 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-15 | 159.5 | 66 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-15 | 162.0 | 45 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-15 | 108.0 | 55 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-15 | 138.0 | 55 | |
N2586 | PI103 | 0.1 | uM | 3 | IL-15 | 103.5 | 62 | ||||
0 | IL-15 | 123.0 | 56 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 3 | IL-15 | 172.0 | 60 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | IL-15 | 267.0 | 41 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-15 | 178.0 | 61 |